Background
Carli Roulston holds a PhD in pharmacology and brings 25 years' experience spanning biomedical research, product development, innovation and commercialisation. She has extensive experience evaluating emerging technologies and developing commercialisation strategies that translate research, intellectual property and specialist capabilities into products, services and new business opportunities.
As Head of Commercial Ventures at Burnet Institute, Carli leads the development of new internal business units and external venture opportunities arising from Burnet's research and capabilities. Her role spans commercial strategy, business model development, and investment and venture creation, with a focus on building sustainable pathways from innovation to impact.
Carli's current role builds on her previous leadership of business development at Burnet, expanding her focus from innovation pipeline development, partnerships and new business opportunities to include the creation and growth of new ventures. Prior to Burnet, she was an innovation consultant and Head of Commercialisation at The Florey Institute, with experience spanning therapeutics, medical devices and digital health.
Qualifications
- PhD, Department of Pharmacology, Monash University,
- BSc (Hons), Department of Pharmacology, Monash University,
- Certificate in Teaching and Learning for Graduate Students, Monash University
- Certificate of Good Clinical Practice, NIDA Clinical Trials Network
Positions
- 2026–present: Head of Commercial Ventures, Burnet Institute
- 2025–2026: Senior Manager, Business Development, Commercialisation and Research Translation, Burnet Institute
- 2024–2025: Senior Innovation Manager, Commercial, Innovation and Industry Partnerships, Burnet Institute
Awards
- 2016 Cass Foundation Science and Medicine Award
- 2014 Brain Foundation Research Award
- 2009 Bethlehem Griffiths Research Foundation Award
